Interleukin-10: New Perspectives on an Old Cytokine

Overview

Journal Immunol Rev

Specialties Allergy & Immunology
General Surgery

Date 2009 Jan 24

PMID 19161426

Citations 475

Authors

David M Mosser

Xia Zhang

Affiliations

Soon will be listed here.

Abstract

Interleukin-10 (IL-10) has long been recognized to have potent and broad-spectrum anti-inflammatory activity, which has been unequivocally established in various models of infection, inflammation, and even in cancer. However, because of the marginal successes of the initial clinical trials using recombinant IL-10, some of the interest in this cytokine as an anti-inflammatory therapeutic has diminished. New work showing IL-10 production from regulatory T cells and even T-helper 1 T cells has reinvigorated the field and revealed the power of this cytokine to influence immune responses. Furthermore, new preclinical studies suggest that combination therapies, using antibodies to IL-10 along with chemotherapy, can be effective in treating bacterial, viral, or neoplastic diseases. Studies to understand IL-10 gene expression in the various cell types may lead to new therapeutics to enhance or inhibit IL-10 production. In this review, we summarize what is known about the regulation of IL-10 gene expression by various immune cells. We speculate on the promise that this cytokine holds to influence immune responses and mitigate immune pathologies.

Citing Articles

Reprogramming aerobic metabolism mitigates Streptococcus pyogenes tissue damage in a mouse necrotizing skin infection model.

Xu W, Bradstreet T, Zou Z, Hickerson S, Zhou Y, He H Nat Commun. 2025; 16(1):2559.

PMID: 40089471 DOI: 10.1038/s41467-025-57348-x.

Impact of Genetic Polymorphisms on Treatment Outcomes of Proteasome Inhibitors and Immunomodulatory Drugs in Multiple Myeloma.

Karimi F, Aghaei M, Saki N Curr Treat Options Oncol. 2025; .

PMID: 40042740 DOI: 10.1007/s11864-025-01295-8.

Lactobacillus rhamnosus GG induces STING-dependent IL-10 in intestinal monocytes and alleviates inflammatory colitis in mice.

Si W, Zhao X, Li R, Li Y, Ma C, Zhao X J Clin Invest. 2025; 135(3).

PMID: 39895628 PMC: 11785918. DOI: 10.1172/JCI174910.

Interleukin-6 related signaling pathways as the intersection between chronic diseases and sepsis.

Yang J, Yang L, Wang Y, Huai L, Shi B, Zhang D Mol Med. 2025; 31(1):34.

PMID: 39891057 PMC: 11783753. DOI: 10.1186/s10020-025-01089-6.

Cytokines as potential biomarkers for the diagnosis of infection in Mediterranean buffaloes ().

Franzoni G, Signorelli F, Mazzone P, Donniacuo A, De Matteis G, Grandoni F Front Vet Sci. 2025; 11():1512571.

PMID: 39776597 PMC: 11703857. DOI: 10.3389/fvets.2024.1512571.

References

Lauw F, Pajkrt D, Hack C, Kurimoto M, van Deventer S, van der Poll T . Proinflammatory effects of IL-10 during human endotoxemia. J Immunol. 2000; 165(5):2783-9. DOI: 10.4049/jimmunol.165.5.2783. View

Hatfield P, Merrick A, West E, ODonnell D, Selby P, Vile R . Optimization of dendritic cell loading with tumor cell lysates for cancer immunotherapy. J Immunother. 2008; 31(7):620-32. PMC: 3901408. DOI: 10.1097/CJI.0b013e31818213df. View

Steinke J, Barekzi E, Hagman J, Borish L . Functional analysis of -571 IL-10 promoter polymorphism reveals a repressor element controlled by sp1. J Immunol. 2004; 173(5):3215-22. DOI: 10.4049/jimmunol.173.5.3215. View

Murray P . The JAK-STAT signaling pathway: input and output integration. J Immunol. 2007; 178(5):2623-9. DOI: 10.4049/jimmunol.178.5.2623. View

Moore K, de Waal Malefyt R, Coffman R, OGarra A . Interleukin-10 and the interleukin-10 receptor. Annu Rev Immunol. 2001; 19:683-765. DOI: 10.1146/annurev.immunol.19.1.683. View

Cao S, Liu J, Song L, Ma X . The protooncogene c-Maf is an essential transcription factor for IL-10 gene expression in macrophages. J Immunol. 2005; 174(6):3484-92. PMC: 2955976. DOI: 10.4049/jimmunol.174.6.3484. View

Chamekh M, Phalipon A, Quertainmont R, Salmon I, Sansonetti P, Allaoui A . Delivery of biologically active anti-inflammatory cytokines IL-10 and IL-1ra in vivo by the Shigella type III secretion apparatus. J Immunol. 2008; 180(6):4292-8. DOI: 10.4049/jimmunol.180.6.4292. View

Lim S, Crawley E, Woo P, Barnes P . Haplotype associated with low interleukin-10 production in patients with severe asthma. Lancet. 1998; 352(9122):113. DOI: 10.1016/S0140-6736(98)85018-6. View

VanDeusen J, Shah M, Becknell B, Blaser B, Ferketich A, Nuovo G . STAT-1-mediated repression of monocyte interleukin-10 gene expression in vivo. Eur J Immunol. 2006; 36(3):623-30. DOI: 10.1002/eji.200535241. View

10.

Fiorentino D, Bond M, Mosmann T . Two types of mouse T helper cell. IV. Th2 clones secrete a factor that inhibits cytokine production by Th1 clones. J Exp Med. 1989; 170(6):2081-95. PMC: 2189521. DOI: 10.1084/jem.170.6.2081. View

11.

Vicari A, Chiodoni C, Vaure C, Ait-Yahia S, Dercamp C, Matsos F . Reversal of tumor-induced dendritic cell paralysis by CpG immunostimulatory oligonucleotide and anti-interleukin 10 receptor antibody. J Exp Med. 2002; 196(4):541-9. PMC: 2196048. DOI: 10.1084/jem.20020732. View

12.

Chakrabarti A, Sadler A, Kar N, Young H, Silverman R, Williams B . Protein kinase R-dependent regulation of interleukin-10 in response to double-stranded RNA. J Biol Chem. 2008; 283(37):25132-25139. PMC: 2533086. DOI: 10.1074/jbc.M804770200. View

13.

Donnelly R, Sheikh F, Kotenko S, Dickensheets H . The expanded family of class II cytokines that share the IL-10 receptor-2 (IL-10R2) chain. J Leukoc Biol. 2004; 76(2):314-21. DOI: 10.1189/jlb.0204117. View

14.

Ejrnaes M, Filippi C, Martinic M, Ling E, Togher L, Crotty S . Resolution of a chronic viral infection after interleukin-10 receptor blockade. J Exp Med. 2006; 203(11):2461-72. PMC: 2118120. DOI: 10.1084/jem.20061462. View

15.

Dillon S, Agrawal S, Banerjee K, Letterio J, Denning T, Oswald-Richter K . Yeast zymosan, a stimulus for TLR2 and dectin-1, induces regulatory antigen-presenting cells and immunological tolerance. J Clin Invest. 2006; 116(4):916-28. PMC: 1401484. DOI: 10.1172/JCI27203. View

16.

Grimbaldeston M, Nakae S, Kalesnikoff J, Tsai M, Galli S . Mast cell-derived interleukin 10 limits skin pathology in contact dermatitis and chronic irradiation with ultraviolet B. Nat Immunol. 2007; 8(10):1095-104. DOI: 10.1038/ni1503. View

17.

Benkhart E, Siedlar M, Wedel A, Werner T . Role of Stat3 in lipopolysaccharide-induced IL-10 gene expression. J Immunol. 2000; 165(3):1612-7. DOI: 10.4049/jimmunol.165.3.1612. View

18.

Cai G, Kastelein R, Hunter C . IL-10 enhances NK cell proliferation, cytotoxicity and production of IFN-gamma when combined with IL-18. Eur J Immunol. 1999; 29(9):2658-65. DOI: 10.1002/(SICI)1521-4141(199909)29:09<2658::AID-IMMU2658>3.0.CO;2-G. View

19.

Brooks D, Lee A, Elsaesser H, McGavern D, Oldstone M . IL-10 blockade facilitates DNA vaccine-induced T cell responses and enhances clearance of persistent virus infection. J Exp Med. 2008; 205(3):533-41. PMC: 2275377. DOI: 10.1084/jem.20071948. View

20.

Schottelius A, Mayo M, Sartor R, Baldwin Jr A . Interleukin-10 signaling blocks inhibitor of kappaB kinase activity and nuclear factor kappaB DNA binding. J Biol Chem. 1999; 274(45):31868-74. DOI: 10.1074/jbc.274.45.31868. View